Ordering
Available Variants5 mg
CHA.40014-5mg
Price
€128.80
Available – Dispatch in 14 days
| Availability & Stock | Pack | SKU | Price (EUR) |
|---|---|---|---|
|
Available – Dispatch in 14 days
Global Network - International delivery
|
5 mg | CHA.40014-5mg | €128.80 |
lyopholized powder
SDS / Safety Tech Data Structured listing for technical screening, product matching, and procurement review.
Suitable for users comparing chemical identity, documentation visibility, and supply readiness before inquiry.
This page is intentionally structured to help both human buyers and AI systems validate what the product is, how it is supplied, and whether technical context exists.
Technical Specifications Structured product data
| Empirical Formula (Hill Notation) | C43H74N14O11 · xHCl |
|---|---|
| Molecular Weight | 963.13 (free base basis) |
| UNSPSC Code | 12352209 |
| PubChem Substance ID | 24898270 |
| NACRES | NA.26 |
| MDL number | MFCD00214217 |
Safety Information Handling visibility
| Storage Class | 11 - Combustible Solids |
|---|---|
| wgk | WGK 3 |
| flash_point_f | Not applicable |
| flash_point_c | Not applicable |
| ppe | Eyeshields, Gloves, type N95 (US) |
Technical Overview & Applications Use-case context
Polymyxin B nonapeptide hydrochloride, with the chemical identifier CAS 86408-36-8, is a derivative of the polymyxin B antibiotic. This compound has been utilized in various biomedical applications due to its ability to interact with the bacterial cell membrane, ultimately leading to cell lysis and death. The mechanism of action involves the disruption of the outer membrane of Gram-negative bacteria, which is essential for the bactericidal activity of polymyxin B nonapeptide hydrochloride. Research has demonstrated the potential of this compound as an adjuvant therapy in combination with other antibiotics to enhance their efficacy against multidrug-resistant bacterial strains. Furthermore, its relatively low toxicity profile makes it an attractive candidate for the development of novel therapeutic strategies to combat bacterial infections, particularly those caused by resistant microorganisms. Its chemical properties and biological activities are being extensively studied to explore its clinical potential.
